Cannabis Bioscience International Holdings Reports Director/Officer Changes
Ticker: CBIH · Form: 8-K · Filed: Nov 26, 2024 · CIK: 1411057
| Field | Detail |
|---|---|
| Company | Cannabis Bioscience International Holdings, INC. (CBIH) |
| Form Type | 8-K |
| Filed Date | Nov 26, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update
TL;DR
Cannabis Bioscience Intl Holdings filed an 8-K detailing director/officer changes and former company names.
AI Summary
Cannabis Bioscience International Holdings, Inc. filed an 8-K on November 26, 2024, reporting changes in its board of directors and officers, along with other events and financial statements. The filing also notes the company's former names, China Infrastructure Construction Corp and Fidelity Aviation Corp, with name changes occurring in 2009 and 2007 respectively. The report was filed as of November 22, 2024.
Why It Matters
Changes in a company's board and officers can signal shifts in strategy, management stability, or governance, which are important factors for investors to consider.
Risk Assessment
Risk Level: low — This filing is primarily procedural, reporting changes in directors and officers, and does not contain significant financial or operational news that would inherently increase risk.
Key Players & Entities
- Cannabis Bioscience International Holdings, Inc. (company) — Registrant
- China Infrastructure Construction Corp (company) — Former company name
- Fidelity Aviation Corp (company) — Former company name
- November 22, 2024 (date) — Date of earliest event reported
- November 26, 2024 (date) — Filing date
FAQ
What specific changes were made to the board of directors or officers?
The filing indicates "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers" as an item of report, but the specific details of these changes are not provided in the provided text.
What other events are reported in this 8-K filing?
The filing lists "Other Events" and "Financial Statements and Exhibits" as additional items of report, but the specific content of these sections is not detailed in the provided text.
When was Cannabis Bioscience International Holdings, Inc. previously known by other names?
The company was formerly known as China Infrastructure Construction Corp, with a name change date of September 16, 2009, and as Fidelity Aviation Corp, with a name change date of August 29, 2007.
What is the Standard Industrial Classification (SIC) code for Cannabis Bioscience International Holdings, Inc.?
The SIC code listed is 8731, which corresponds to SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH.
What is the business and mailing address for Cannabis Bioscience International Holdings, Inc.?
The business and mailing address is 6201 Bonhomme Road, Suite 435S, Houston, TX 77036.
Filing Stats: 1,224 words · 5 min read · ~4 pages · Grade level 16 · Accepted 2024-11-26 17:26:02
Filing Documents
- cannabisbio_8k.htm (8-K) — 30KB
- cannabisbio_ex1001.htm (EX-10.1) — 45KB
- cannabisbio_ex1002.htm (EX-10.2) — 28KB
- image_003.jpg (GRAPHIC) — 15KB
- 0001683168-24-008403.txt ( ) — 314KB
- cbih-20241122.xsd (EX-101.SCH) — 3KB
- cbih-20241122_lab.xml (EX-101.LAB) — 33KB
- cbih-20241122_pre.xml (EX-101.PRE) — 24KB
- cannabisbio_8k_htm.xml (XML) — 3KB
02 Departure of Directors
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 22, 2024, the Board of Directors, acting under the Registrant's by-laws, increased the number of persons comprising the Board of Directors to four from three and filled the vacancy thus created with Charles Tamburello, who will serve from December 1, 2024, until the next annual meeting of shareholders. Mr. Tamburello is 51 years of age. He was recruited because of his expertise in mergers and acquisitions, most recently as chief executive officer of Global Discovery Group, Inc. ("Global"). in Miami, Florida. There is no arrangement or understanding between Mr. Tamburello and the Registrant, or to the knowledge of the Registrant, between him and any other person, pursuant to which he was selected. The Registrant and Mr. Tamburello have entered into a Director Agreement, dated November 22, 2024 (the "Director Agreement"), relating to his service as a director. Under the Director Agreement, Mr. Tamburello will receive no cash compensation and equity compensation of 100,000,000 shares of the Registrant's common stock, but if he is removed for cause or resigns before November 30, 2025, he will, without consideration, sell, assign and transfer to the Company 8,333,333 shares of Common Stock for each full month between the date of such removal or resignation and October 31, 2025. The Registrant is required to indemnify Mr. Tamburello if he becomes involved in, or is threatened to become involved in, any claim, action, or proceeding or if a claim or action is made or threatened against him due to his role as a director of the Registrant, and against any and all losses, claims, damages, expenses, and liabilities, including any investigation, legal fees, and other expenses incurred in connection with, and any amounts paid in settlement of, any such claim, action or proceeding. (collectively "Liabilities"
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Exhibit Description 10.1 Director Agreement, dated November 22, 2024, by and between the Registrant and Charles Tamburello 10.2 Nondisclosure / Noncircumvent Agreement, dated March 12, 2024, by and between Global Discovery Group, Inc. and the Registrant 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. By: /s/ Dante Picazo Dante Picazo Chief Executive Officer Dated: November 26, 2024 3